自動乳房超音波検査システム(ABUS)の世界市場2019-2023

◆英語タイトル:Global Automated Breast Ultrasound Systems(ABUS) Market 2019-2023
◆商品コード:IRTNTR31086
◆発行会社(リサーチ会社):Technavio
◆発行日:2019年3月27日
◆ページ数:117
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥267,500見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥321,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥428,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、自動乳房超音波検査システム(ABUS)の世界市場について調査・分析し、市場概要、市場環境、自動乳房超音波検査システム(ABUS)市場規模、エンドユーザー別(病院及びクリニック、診断センター)分析、市場動向、競争環境、主要地域別市場規模(北米、ヨーロッパ、アジアなど)、関連企業情報などを含め、以下の構成でお届け致します。
・エグゼクティブサマリー
・調査範囲・調査手法
・自動乳房超音波検査システム(ABUS)の世界市場概要
・自動乳房超音波検査システム(ABUS)の世界市場環境
・自動乳房超音波検査システム(ABUS)の世界市場動向
・自動乳房超音波検査システム(ABUS)の世界市場規模
・自動乳房超音波検査システム(ABUS)の世界市場:業界構造分析
・自動乳房超音波検査システム(ABUS)の世界市場:エンドユーザー別(病院及びクリニック、診断センター)
・自動乳房超音波検査システム(ABUS)の世界市場:地域別市場規模・分析
・自動乳房超音波検査システム(ABUS)の北米市場規模・予測
・自動乳房超音波検査システム(ABUS)のヨーロッパ・中東・アフリカ市場規模・予測
・自動乳房超音波検査システム(ABUS)のアジア太平洋市場規模・予測
・自動乳房超音波検査システム(ABUS)の主要国分析
・自動乳房超音波検査システム(ABUS)の世界市場:成長要因、課題
・自動乳房超音波検査システム(ABUS)の世界市場:競争環境
・自動乳房超音波検査システム(ABUS)の世界市場:関連企業情報(ベンダー分析)
【レポートの概要】

About this market
The lack of efficacy in breast diagnostic imaging and the need to reduce false-positive biopsies are leading companies to focus on product range expansion by developing next-generation and integrated ABUS. End-users are focusing on providing specialized care and treatment. Hence, many end-users are installing newly launched ABUS in their diagnostic units. The increasing number of ABUS launches and integrated tools for ABUS will drive market growth during the forecast period. Technavio’s analysts have predicted that the automated breast ultrasound systems (ABUS) market will register a CAGR of more than 14% by 2023.
Market Overview
Increasing demand for breast imaging products owing to growing prevalence of breast cancer cases
The growing number of breast cancer cases is boosting the demand for ABUS. Factors such as increasing age, a family history of breast cancer, radiation exposure, and post-menopausal hormone therapy can lead to breast cancer. Oncologists prefer using breast imaging products such as ABUS due to their efficacy in diagnostic results. With the growing number of breast cancer cases globally, the need for ABUS increases, thereby boosting market growth.
Product recall of ABUS due to labeling and design issues
End-users rely on companies that provide high-quality products, which can provide efficacious results. However, if any product enters the market with a deformity, it is either recalled by the firm that has developed it or regulatory bodies such as the US FDA and the Therapeutic Goods Administration (TGA). Product recalls can affect the brand image of the company and can lead to a reduction in sales revenue.
For the detailed list of factors that will drive and challenge the growth of the automated breast ultrasound systems (ABUS) market during the 2019-2023, view our report.
Competitive Landscape
The market appears to be moderately concentrated and with the presence of limited vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market’s competitive landscape and offering information on the products offered by companies.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY END-USER
• Market segmentation by end-user
• Comparison by end-user
• Hospitals and clinics – Market size and forecast 2018-2023
• Diagnostic centers – Market size and forecast 2018-2023
• Market opportunity by end-user
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Funding and capital investments for the development of ABUS
• Growing focus on courses and medical exhibition for breast imaging products
• Growing focus on development of integrated and innovative ABUS
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• GE Healthcare
• Hitachi, Ltd.
• Koninklijke Philips N.V.
• Siemens Healthineers AG
• SonoCiné
PART 13: APPENDIX
• Research methodology
• List of abbreviations
PART 14: EXPLORE TECHNAVIO

Exhibit 01: Global medical imaging market
Exhibit 02: Segments of global medical imaging market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: End-user – Market share 2018-2023 (%)
Exhibit 18: Comparison by end-user
Exhibit 19: Hospitals and clinics – Market size and forecast 2018-2023 ($ millions)
Exhibit 20: Hospitals and clinics – Year-over-year growth 2019-2023 (%)
Exhibit 21: Diagnostic centers – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Diagnostic centers – Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by end-user
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America – Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 31: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 33: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 34: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Breast cancer cases in US states
Exhibit 38: ABUS launches by companies and market impact analysis
Exhibit 39: Product recalls: Overview
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Vendor landscape
Exhibit 42: Landscape disruption
Exhibit 43: Vendors covered
Exhibit 44: Vendor classification
Exhibit 45: Market positioning of vendors
Exhibit 46: GE Healthcare – Vendor overview
Exhibit 47: GE Healthcare – Business segments
Exhibit 48: GE Healthcare – Organizational developments
Exhibit 49: GE Healthcare – Geographic focus
Exhibit 50: GE Healthcare – Segment focus
Exhibit 51: GE Healthcare – Key offerings
Exhibit 52: GE Healthcare – Key customers
Exhibit 53: Hitachi, Ltd. – Vendor overview
Exhibit 54: Hitachi, Ltd. – Product segments
Exhibit 55: Hitachi, Ltd. – Organizational developments
Exhibit 56: Hitachi, Ltd. – Geographic focus
Exhibit 57: Hitachi, Ltd. – Segment focus
Exhibit 58: Hitachi, Ltd. – Key offerings
Exhibit 59: Hitachi, Ltd. – Key customers
Exhibit 60: Koninklijke Philips N.V. – Vendor overview
Exhibit 61: Koninklijke Philips N.V. – Business segments
Exhibit 62: Koninklijke Philips N.V. – Organizational developments
Exhibit 63: Koninklijke Philips N.V. – Geographic focus
Exhibit 64: Koninklijke Philips N.V. – Segment focus
Exhibit 65: Koninklijke Philips N.V. – Key offerings
Exhibit 66: Koninklijke Philips N.V. – Key customers
Exhibit 67: Siemens Healthineers AG – Vendor overview
Exhibit 68: Siemens Healthineers AG – Business segments
Exhibit 69: Siemens Healthineers AG – Organizational developments
Exhibit 70: Siemens Healthineers AG – Geographic focus
Exhibit 71: Siemens Healthineers AG – Segment focus
Exhibit 72: Siemens Healthineers AG – Key offerings
Exhibit 73: Siemens Healthineers AG – Key customers
Exhibit 74: SonoCiné – Vendor overview
Exhibit 75: SonoCiné – Organizational developments
Exhibit 76: SonoCiné – Key offerings
Exhibit 77: SonoCiné – Key customers
Exhibit 78: Validation techniques employed for market sizing



【掲載企業】

GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthineers AG, SonoCiné

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[自動乳房超音波検査システム(ABUS)の世界市場2019-2023]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆